DK0676409T3 - Erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler - Google Patents

Erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler

Info

Publication number
DK0676409T3
DK0676409T3 DK95400763T DK95400763T DK0676409T3 DK 0676409 T3 DK0676409 T3 DK 0676409T3 DK 95400763 T DK95400763 T DK 95400763T DK 95400763 T DK95400763 T DK 95400763T DK 0676409 T3 DK0676409 T3 DK 0676409T3
Authority
DK
Denmark
Prior art keywords
pharmaceuticals
processes
preparation
erythromycin derivatives
erythromycin
Prior art date
Application number
DK95400763T
Other languages
Danish (da)
English (en)
Inventor
Jean-Francois Chantot
Martret Odile Le
Constantin Agouridas
Alexis Denis
Yannick Benedetti
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK0676409T3 publication Critical patent/DK0676409T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK95400763T 1994-04-08 1995-04-06 Erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler DK0676409T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9404154A FR2718450B1 (fr) 1994-04-08 1994-04-08 Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Publications (1)

Publication Number Publication Date
DK0676409T3 true DK0676409T3 (da) 2003-06-23

Family

ID=9461886

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95400763T DK0676409T3 (da) 1994-04-08 1995-04-06 Erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler

Country Status (49)

Country Link
US (2) US5656607A (enExample)
EP (1) EP0676409B1 (enExample)
JP (1) JP3000023B2 (enExample)
KR (1) KR100317148B1 (enExample)
CN (1) CN1059445C (enExample)
AP (1) AP587A (enExample)
AT (1) ATE234853T1 (enExample)
AU (1) AU684939B2 (enExample)
BG (1) BG61916B1 (enExample)
BR (1) BR9506147A (enExample)
CA (1) CA2164638C (enExample)
CO (1) CO4370097A1 (enExample)
CZ (1) CZ296005B6 (enExample)
DE (1) DE69529934T2 (enExample)
DK (1) DK0676409T3 (enExample)
DZ (1) DZ1869A1 (enExample)
EE (1) EE04498B1 (enExample)
ES (1) ES2189820T3 (enExample)
FI (1) FI111264B (enExample)
FR (1) FR2718450B1 (enExample)
GB (1) GB2288174A (enExample)
GE (1) GEP19991836B (enExample)
HR (1) HRP950217B1 (enExample)
HU (1) HU215396B (enExample)
IL (1) IL112954A (enExample)
IS (1) IS1865B (enExample)
JO (1) JO1850B1 (enExample)
LV (1) LV11182B (enExample)
MA (1) MA23501A1 (enExample)
MD (1) MD663G2 (enExample)
MY (1) MY114672A (enExample)
NO (1) NO308361B1 (enExample)
NZ (1) NZ284498A (enExample)
OA (1) OA10200A (enExample)
PE (1) PE2896A1 (enExample)
PL (1) PL180837B1 (enExample)
PT (1) PT676409E (enExample)
RO (1) RO115634B1 (enExample)
RU (1) RU2141965C1 (enExample)
SA (1) SA97170757A (enExample)
SI (1) SI0676409T1 (enExample)
SK (1) SK284079B6 (enExample)
SV (1) SV1995000018A (enExample)
TN (1) TNSN95026A1 (enExample)
TW (1) TW316908B (enExample)
UA (1) UA44705C2 (enExample)
WO (1) WO1995027720A1 (enExample)
YU (1) YU49221B (enExample)
ZA (1) ZA952059B (enExample)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2732023B1 (fr) * 1995-03-22 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2745289B1 (fr) * 1996-02-28 1998-05-29 Roussel Uclaf Nouveaux derives de l'acide 1(2h) quinoleine carboxylique, leur procede de preparation et leur application a la synthese de produits doues de proprietes antibiotiques
US5750510A (en) * 1997-04-04 1998-05-12 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
DE69723848T2 (de) * 1996-05-07 2004-07-01 Abbott Laboratories, Abbott Park 3-descladinose-2,3-anhydroerythromycin-derivate
FR2748746B1 (fr) * 1996-05-14 1998-08-14 Hoechst Marion Roussel Inc Nouveau procede d'isomerisation du radical methyle en 10 de derives de l'erythromycine
FR2751656B1 (fr) * 1996-07-24 1998-10-16 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
IL128681A0 (en) * 1996-09-04 2000-01-31 Abbott Lab 6-O substituted ketolides having antibacterial activity
FR2757168B1 (fr) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2760017B1 (fr) * 1997-02-27 1999-04-30 Hoechst Marion Roussel Inc Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments
AU4472897A (en) * 1997-03-10 1998-09-29 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
WO1998042720A1 (fr) * 1997-03-24 1998-10-01 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
AU6932098A (en) * 1997-05-09 1998-12-08 Pfizer Products Inc. Erythromycin derivatives
US5922683A (en) * 1997-05-29 1999-07-13 Abbott Laboratories Multicyclic erythromycin derivatives
BR9810021A (pt) * 1997-06-11 2000-09-19 Pfizer Prod Inc Derivados 9-oxima-eritromicina
FR2771008B1 (fr) * 1997-11-17 2000-04-28 Hoechst Marion Roussel Inc Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
HRP980189B1 (en) * 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
ES2243066T3 (es) 1998-09-22 2005-11-16 Pfizer Products Inc. Antibioticos de carbamato y carbazato cetolida.
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
TR200102129T2 (tr) 1998-12-10 2002-01-21 Pfizer Products Inc. Karbamat ve karbazat ketolid antibiyotikleri.
EP1298138B1 (en) * 1998-12-10 2006-11-02 Pfizer Products Inc. Carbamate and Carbazate Ketolide Antibiotics
EP1749832A3 (en) * 1998-12-10 2008-03-26 Pfizer Products Incorporated Carbamate and carbazate ketolide antibiotics
FR2789392B1 (fr) 1999-02-04 2001-10-05 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US6054435A (en) * 1999-03-19 2000-04-25 Abbott Laboratories 6-O-substituted macrolides having antibacterial activity
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
WO2000063224A2 (en) * 1999-04-16 2000-10-26 Kosan Biosciences, Inc. Macrolide antiinfective agents
WO2000062783A2 (en) 1999-04-16 2000-10-26 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
EP1180110A1 (en) * 1999-05-24 2002-02-20 Pfizer Products Inc. 13-methyl-erythromycin derivatives
CA2451391A1 (en) * 2001-07-03 2003-01-16 Chiron Corporation C12 modified erythromycin macrolides and ketolides having antibacterial activity
MXPA04012978A (es) 2002-07-01 2005-09-12 Arkion Life Sciences Llc D B A Proceso y material para la produccion de glucosamina y n-acetilglucosamina.
EP2772254A3 (en) 2003-03-10 2015-03-11 Optimer Pharmaceuticals, Inc. Novel Antibacterial Agents
US7332476B2 (en) * 2003-04-25 2008-02-19 Novartis Ag Pyridyl substituted ketolide antibiotics
US7163924B2 (en) * 2003-04-25 2007-01-16 Chiron Corporation Ketolide derivatives
CA2703475A1 (en) * 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
AU2009308182B2 (en) 2008-10-24 2016-05-19 Cempra Pharmaceuticals, Inc. Biodefenses using triazole-containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
WO2011032052A1 (en) 2009-09-10 2011-03-17 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and mac diseases
WO2011119604A1 (en) 2010-03-22 2011-09-29 Cempra Pharmaceuticals, Inc. Crystalline forms of a macrolide, and uses therefor
DK2571506T3 (en) 2010-05-20 2017-08-28 Cempra Pharmaceuticals Inc PROCEDURES FOR THE MANUFACTURE OF MACROLIDES AND KETOLIDES AND INTERMEDIATES
KR20130120458A (ko) 2010-09-10 2013-11-04 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
US10188674B2 (en) 2012-03-27 2019-01-29 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
AU2014239959A1 (en) 2013-03-14 2015-10-01 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
KR20160020403A (ko) 2013-03-15 2016-02-23 셈프라 파마슈티컬스, 인크. 매크로라이드 항세균제들을 제조하기 위한 수렴 프로세스들
WO2014165792A2 (en) 2013-04-04 2014-10-09 President And Fellows Of Harvard College Macrolides and methods of their preparation and use
HK1242920A1 (zh) 2014-10-08 2018-07-06 哈佛大学的校长及成员们 14-元酮内酯及其制备和使用方法
CN107530365A (zh) 2015-03-25 2018-01-02 哈佛大学的校长及成员们 具有修饰的脱氧糖胺糖的大环内酯及其用途
MD1222Z (ro) * 2017-05-31 2018-08-31 ИНСТИТУТ ЭЛЕКТРОННОЙ ИНЖЕНЕРИИ И НАНОТЕХНОЛОГИЙ "D. Ghitu" АНМ Procedeu de tratare a materialului săditor al florilor înainte de plantare
JP7199722B2 (ja) 2019-12-25 2023-01-06 旭精工株式会社 硬貨搬送振分機構及びそれを備えた硬貨識別搬送装置

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868414A (en) * 1973-01-22 1975-02-25 Merck & Co Inc Tetrahydrofluorene carboxylic acids and related compounds
AT342770B (de) * 1975-04-07 1978-04-25 Thomae Gmbh Dr K Verfahren zur herstellung neuer erythromycinderivate
DE2842759A1 (de) * 1978-09-30 1980-04-10 Merck Patent Gmbh Basische aether, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of erythromycin derivatives
FR2692579B1 (fr) * 1992-06-19 1995-06-02 Roussel Uclaf Nouveaux dérivés de la picromycine, leur procédé de préparation et leur application comme médicaments.
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
HRP930014A2 (en) * 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
FR2702480B1 (fr) * 1993-03-09 1995-04-28 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
IS1865B (is) 2003-05-02
LV11182A (lv) 1996-04-20
AU684939B2 (en) 1998-01-08
KR100317148B1 (ko) 2002-06-22
US5760233A (en) 1998-06-02
TW316908B (enExample) 1997-10-01
HRP950217A2 (en) 1997-08-31
LV11182B (en) 1997-04-20
EE04498B1 (et) 2005-06-15
EP0676409A1 (fr) 1995-10-11
HRP950217B1 (en) 2004-06-30
IS4309A (is) 1995-11-17
ZA952059B (en) 1996-03-13
MD663G2 (ro) 1997-07-31
GB9506856D0 (en) 1995-05-24
FI955913A7 (fi) 1995-12-08
AP9500743A0 (en) 1995-07-31
SV1995000018A (es) 1997-10-24
DE69529934T2 (de) 2003-09-04
NO308361B1 (no) 2000-09-04
HU9503505D0 (en) 1996-02-28
JP3000023B2 (ja) 2000-01-17
PE2896A1 (es) 1996-02-12
US5656607A (en) 1997-08-12
GEP19991836B (en) 1999-11-05
PT676409E (pt) 2003-08-29
NO954942L (no) 1996-02-07
CN1059445C (zh) 2000-12-13
HU215396B (hu) 1998-12-28
BR9506147A (pt) 1996-04-16
CZ296005B6 (cs) 2005-12-14
FR2718450B1 (fr) 1997-01-10
AU2310795A (en) 1995-10-30
SK284079B6 (sk) 2004-09-08
OA10200A (fr) 1996-12-18
PL311871A1 (en) 1996-03-18
BG61916B1 (bg) 1998-09-30
SK154695A3 (en) 1996-10-02
CA2164638A1 (fr) 1995-10-19
SI0676409T1 (en) 2003-06-30
CZ322395A3 (en) 1996-08-14
NO954942D0 (no) 1995-12-06
MA23501A1 (fr) 1995-12-31
MD663F1 (ro) 1997-01-31
DZ1869A1 (fr) 2002-02-17
DE69529934D1 (de) 2003-04-24
UA44705C2 (uk) 2002-03-15
FI955913A0 (fi) 1995-12-08
RO115634B1 (ro) 2000-04-28
IL112954A0 (en) 1995-06-29
HUT73772A (en) 1996-09-30
ES2189820T3 (es) 2003-07-16
FI111264B (fi) 2003-06-30
CN1126997A (zh) 1996-07-17
SA97170757A (ar) 2005-12-03
WO1995027720A1 (fr) 1995-10-19
IL112954A (en) 2000-07-16
NZ284498A (en) 1997-07-27
GB2288174A (en) 1995-10-11
YU21695A (sh) 1997-12-05
RU2141965C1 (ru) 1999-11-27
MY114672A (en) 2002-12-31
CA2164638C (fr) 2003-12-30
BG100150A (bg) 1996-06-28
TNSN95026A1 (fr) 1996-02-06
CO4370097A1 (es) 1996-10-07
PL180837B1 (pl) 2001-04-30
EP0676409B1 (fr) 2003-03-19
JO1850B1 (en) 1995-12-27
JPH07278177A (ja) 1995-10-24
AP587A (en) 1997-04-29
ATE234853T1 (de) 2003-04-15
FR2718450A1 (fr) 1995-10-13
EE9500080A (et) 1996-12-16
YU49221B (sh) 2004-11-25

Similar Documents

Publication Publication Date Title
DK0676409T3 (da) Erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
NO964654D0 (no) Nye erytromycinderivater, fremgangsmåte for deres fremstilling og deres anvendelse som legemidler
DK0885234T3 (da) Nye erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
NO993003D0 (no) Sulfonamid-derivater, fremgangsmÕte for deres fremstilling og deres anvendelse som medikamenter
DK0740668T3 (da) Tetracykliske derivater, fremgangsmåde til deres fremstilling og deres anvendelse
NO20006029D0 (no) Pyrazolinderivater, deres fremstilling og anvendelse som legemidler
NO991815D0 (no) Oksadiazoler, fremgangsmÕter for deres fremstilling og deres anvendelse som medikamenter
DK1017670T3 (da) Benzamidoximderivater, mellemprodukter og fremgangsmåder til deres fremstilling og deres anvendelse som fungicider
NO963506D0 (no) 4-Heterocyklyl-substituerte kinazolin-derivater, fremgangsmåte for fremstilling derav og deres anvendelse som anti-kreftmidler
DK1202733T3 (da) 3(5)-amino-pyrazolderivater, fremgangsmåde til deres fremstilling og deres anvendelse som antitumormidler
NO994671D0 (no) Aryl- eller heteroarylsulfonamid-substituerte hydroksamsyrederivater, fremgangsmaate til fremstillint derav og deres anvendelse som farmasöytika
DK641589A (da) N-aryl-azetidinoner, fremgangsmaade til deres fremstilling og deres anvendelse som elastaseinhibitorer
NO20000294D0 (no) Derivater av acylpiperazinylpyrimidiner, deres fremstilling og anvendelse som legemidler
DK1045856T3 (da) Nye aromatiske amider, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
DK1016669T3 (da) Nye erythromycinderivater, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler
DK0770059T3 (da) Substituerede benzamidiner, deres fremstilling og deres anvendelse som lægemidler
DK1004592T3 (da) Nye erythromycinderivater, deres fremstilling og deres anvendelse som medikamenter
DK1015421T3 (da) Nye phenylamidinderivater, fremgangsmåder til deres fremstilling og deres anvendelse som lægemidler
DK0903339T3 (da) Biphenylsulfonylcyanamid, fremgangsmåde til deres fremstilling og deres anvendelse som medikament
DK0912509T3 (da) Distamycinderivater, fremgangsmåde til fremstilling deraf og deres anvendelse som antitumor- og antivirale midler
DK0795547T3 (da) (Aminoalkyl- og acylaminoalkyl-oxy)benzyloxyquinoliner, fremgangsmåde til deres fremstilling og deres anvendelse som bradyk
NO960272D0 (no) Oksatiolaner, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder de samme
NO308362B1 (no) 10,13,15-trioksatrisyklo[9.2.1.19.6]pentadekanonderivater, fremgangsmÕte for deres fremstilling og legemidler som inneholder disse forbindelsene
DK0727416T3 (da) Substituerede benzensulfonylurinstoffer og -thiourinstoffer, og fremgangsmåde til deres fremstilling, deres anvendelse som
NO983860D0 (no) Nye triazolopuriner, fremgangsmÕte for fremstilling av dem og deres anvendelse som legemidler